Iikura Y, Inui H, Obata T, Nagakura T, Sugimoto H, Lee T H, Kay A B
Department of Allergy and Immunology, National Children's Medical Research Centre, Tokyo, Japan.
N Engl Reg Allergy Proc. 1988 May-Jun;9(3):203-7. doi: 10.2500/108854188779023423.
Disodium cromoglycate, prednisolone, beclomethasone and salbutamol were administered prior to the cycle ergometer exercise task separately to different groups of children with exercise-induced dual asthmatic reaction. Pre-treatment with disodium cromoglycate of ten asthmatics totally inhibited the dual reaction. Prednisolone treatment of eleven asthmatics and beclomethasone treatment of five asthmatics did not inhibit the early response but only the late response. Salbutamol treatment of ten asthmatics mainly inhibited the early phase reaction. Changes in neutrophil chemotactic activity correlated with airflow limitation in the disodium cromoglycate and prednisolone study, however, there were some discrepancies between the changes in FEV1 and neutrophil chemotactic activity in the beclomethasone and salbutamol studies. These findings suggest that exercise-induced dual asthmatic reaction are modified by disodium cromoglycate, prednisolone, beclomethasone or salbutamol in a mechanism which may be different in each drug and that there are similarities in the inflammatory responses in antigen- and exercise-induced dual asthmatic responses.
色甘酸钠、泼尼松龙、倍氯米松和沙丁胺醇在进行自行车测力计运动任务之前,分别给予不同组患有运动诱发双重哮喘反应的儿童。对10名哮喘患者进行色甘酸钠预处理可完全抑制双重反应。对11名哮喘患者使用泼尼松龙治疗以及对5名哮喘患者使用倍氯米松治疗均未抑制早期反应,仅抑制了晚期反应。对10名哮喘患者使用沙丁胺醇治疗主要抑制了早期反应。在色甘酸钠和泼尼松龙研究中,中性粒细胞趋化活性的变化与气流受限相关,然而,在倍氯米松和沙丁胺醇研究中,第一秒用力呼气容积(FEV1)的变化与中性粒细胞趋化活性之间存在一些差异。这些发现表明,色甘酸钠、泼尼松龙、倍氯米松或沙丁胺醇可改变运动诱发的双重哮喘反应,其机制可能因药物而异,并且在抗原诱发和运动诱发的双重哮喘反应中,炎症反应存在相似之处。